← Open Payments lookup

SHERRY WALLMARKER: Open Payments

NPI 1578946356 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,788 in 128 payments from 16 companies in 2025. Trend: 2023 $1,785 · 2024 $2,028 · 2025 $2,788

Food & beverage: $2,678Education: $109
CompanyPaymentsAmount
ABBVIE INC.40$733
Madrigal Pharmaceuticals13$454
Salix Pharmaceuticals, a division of Bausch Health US, LLC20$425
Janssen Biotech, Inc.16$339
Takeda Pharmaceuticals U.S.A., Inc.10$207
Gilead Sciences, Inc.6$158
Aimmune Therapeutics, Inc.6$142
QOL Medical, LLC3$86
Phathom Pharmaceuticals, Inc.5$83
GENZYME CORPORATION2$42

Products named: REZDIFFRA, XIFAXAN, TREMFYA, LINZESS, RINVOQ, ENTYVIO, CREON, ZENPEP.

Industry payments across GA — which companies pay providers there.